Ellevest, Inc. Gemini Therapeutics, Inc. Transaction History

Ellevest, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 02, 2022	SELL	$1.31 - $2.01 $61 - $94	-47 Reduced 44.34%	59 $0
Q2 2022 Jul 18, 2022	BUY	$1.22 - $1.73 $129 - $183	106 New	106 $0
Q1 2022 Apr 19, 2022	SELL	$1.29 - $3.08 $47 - $113	-37 Closed	0 $0
Q4 2021 Jan 24, 2022	BUY	$2.39 - $4.0 $88 - $148	37 New	37 $0

2.44M

Ticker GMTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,244,500
Market Cap $1.05B
Description
Gemini Therapeutics, Inc., a clinical stage precision medicine company, engages in developing various therapeutic compounds for treating genetically defined age-related macular degeneration (AMD). Its lead candidate is GEM103, a recombinant form of the human complement factor H protein to treat dry AMD patients. The company also develops GEM307 ...

Get notified when there are updates to the investment portfolio of Ellevest, Inc., based on Form 13F filings with the SEC.

Stay updated on Ellevest, Inc. with notifications on news.